1. BLOOD-BASED BIOMARKER CHANGES IN A PHASE 2B TRIAL ASSESSING LOMECEL-B IN OLDER ADULTS WITH FRAILTY. (20th December 2022) Authors: Ramdas, Kevin; Mehranfard, Danial; Naioti, Eric; Green, Geoff; McClain-Moss, Lisa; Gincel, Dan; Hare, Joshua; Oliva, Anthony Journal: Innovation in aging Issue: Volume 6(2022)Supplement 1 Page Start: 562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The Effects of Multiple Doses of Lomecel‐B, Longeveron' s Cell‐based Therapy, on Alzheimer's disease: Study Design and Rationale of this Phase 2a Multi‐ center Clinical trial. (20th December 2022) Authors: Ramdas, Kevin N.; Brody, Mark; Herskowitz, Brad; Agronin, Marc; Ruiz, Jorge G; Fuquay, Ana; Rodriguez, Savannah; Mehranfard, Danial; McClain‐Moss, Lisa; Gincel, Dan; Hare, Joshua M.; Oliva, Anthony A. Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗